Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (211-220 of 365) with videos related to

Pageof 37
Sort By:
Cureus|September 9, 2025
Prognostic Value of Perioperative Serum Creatinine Kinase Levels for Metachronous Colorectal Liver MetastasisYu Matsumoto, Yuichiro Otsuka, Hiroka Hosaka, et al.
Molecular and Clinical Oncology|December 28, 2020
Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancerMitsunori Ushigome, Hideaki Shimada, Yoshihiro Nabeya, et al.
International Cancer Conference Journal|January 25, 2021
Successful treatment of advanced pancreatic leiomyosarcoma treated with gemcitabine plus <i>nab</i>-paclitaxel: a case report and literature reviewYoshinori Kikuchi, Yusuke Nishikawa, Makoto Amanuma, et al.
Oncology Letters|August 5, 2024
Low serum creatine kinase level is associated with poor prognosis in patients with hepatocellular carcinoma: A retrospective single‑center studyYu Matsumoto, Yuichiro Otsuka, Rei Okada, et al.
Oncology Reports|May 13, 2004
S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancerMikito Mori, Hideaki Shimada, Yoshio Gunji, et al.
Japanese Journal of Clinical Oncology|May 23, 2025
Development of a dynamic prediction model with the inclusion of time-dependent inflammatory biomarker enhances recurrence prediction after curative surgery for stage II or III gastric cancerLarbi Aluariachy, Koji Oba, Yutaka Matsuyama, et al.
Cancer Medicine|December 23, 2019
High serum PD-L1 level is a poor prognostic biomarker in surgically treated esophageal cancerMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Cancer Gene Therapy|September 1, 2004
Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporationMasaya Uesato, Yoshio Gunji, Takeshi Tomonaga, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 1, 2018
Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinomaTakashi Suzuki, Satoshi Yajima, Nobuki Ishioka, et al.
BMC Cancer|May 4, 2017
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathwaysKengo Shimazu, Yuji Tada, Takao Morinaga, et al.
Pageof 37

Showing results (211-220 of 365) with videos related to

Sort By:
Pageof 37
Cureus|September 9, 2025
Prognostic Value of Perioperative Serum Creatinine Kinase Levels for Metachronous Colorectal Liver MetastasisYu Matsumoto, Yuichiro Otsuka, Hiroka Hosaka, et al.
Molecular and Clinical Oncology|December 28, 2020
Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancerMitsunori Ushigome, Hideaki Shimada, Yoshihiro Nabeya, et al.
International Cancer Conference Journal|January 25, 2021
Successful treatment of advanced pancreatic leiomyosarcoma treated with gemcitabine plus <i>nab</i>-paclitaxel: a case report and literature reviewYoshinori Kikuchi, Yusuke Nishikawa, Makoto Amanuma, et al.
Oncology Letters|August 5, 2024
Low serum creatine kinase level is associated with poor prognosis in patients with hepatocellular carcinoma: A retrospective single‑center studyYu Matsumoto, Yuichiro Otsuka, Rei Okada, et al.
Oncology Reports|May 13, 2004
S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancerMikito Mori, Hideaki Shimada, Yoshio Gunji, et al.
Japanese Journal of Clinical Oncology|May 23, 2025
Development of a dynamic prediction model with the inclusion of time-dependent inflammatory biomarker enhances recurrence prediction after curative surgery for stage II or III gastric cancerLarbi Aluariachy, Koji Oba, Yutaka Matsuyama, et al.
Cancer Medicine|December 23, 2019
High serum PD-L1 level is a poor prognostic biomarker in surgically treated esophageal cancerMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Cancer Gene Therapy|September 1, 2004
Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporationMasaya Uesato, Yoshio Gunji, Takeshi Tomonaga, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 1, 2018
Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinomaTakashi Suzuki, Satoshi Yajima, Nobuki Ishioka, et al.
BMC Cancer|May 4, 2017
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathwaysKengo Shimazu, Yuji Tada, Takao Morinaga, et al.
Pageof 37